PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Tingting Xiong

City University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · JOURNAL ARTICLE

Vortioxetine enhances the anti-pancreatic cancer efficacy of gemcitabine through reducing MAOB expression

Frontiers in Pharmacology

Preclinical in vitro and xenograft study proposing a mechanism by which an existing drug may enhance chemotherapy, without clinical efficacy data or human evidence.

Hypothesis-GeneratingKaizhi Luo Cancer Cells and Metastasis Chong Zhang

Study details

DesignPreclinical in vitro and in vivo (xenograft…

InterventionVortioxetine alone and in combination with…

ComparatorGemcitabine alone; control or wildtype cell…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support